» Articles » PMID: 38693428

Hypoxia-inducible Factor 3α1 Increases Epithelial-to-mesenchymal Transition and Iron Uptake to Drive Colorectal Cancer Liver Metastasis

Overview
Journal Br J Cancer
Specialty Oncology
Date 2024 May 1
PMID 38693428
Authors
Affiliations
Soon will be listed here.
Abstract

Background/objectives: Hypoxia-inducible factor (HIF)-3α1's role in colorectal cancer (CRC) cells, especially its effects on epithelial-mesenchymal transition (EMT), zinc finger E-box binding homeobox 2 (ZEB2) gene expression, and iron metabolism, remains largely unstudied. This research sought to elucidate these relationships.

Methods: RNA-seq was conducted to investigate the impact of HIF-3α1 overexpression in CRC cells. Dual-luciferase reporter assays assessed the direct targeting of ZEB2 by HIF-3α1. Scratch assays measured changes in cell migration following HIF-3α1 overexpression and ZEB2 knockdown. The effects of HIF-3α1 overexpression on colon tumour growth and liver metastasis were examined in vivo. Iron chelation was used to explore the role of iron metabolism in HIF-3α1-mediated EMT and tumour growth.

Results: HIF-3α1 overexpression induced EMT and upregulated ZEB2 expression, enhancing cancer cell migration. ZEB2 knockdown reduced mesenchymal markers and cell migration. HIF-3α1 promoted colon tumour growth and liver metastasis, increased transferrin receptor (TFRC) expression and cellular iron levels, and downregulated HIF-1α, HIF-2α, and NDRG1. Iron chelation mitigated HIF-3α1-mediated EMT, tumour growth, and survival.

Conclusions: HIF-3α1 plays a critical role in colon cancer progression by promoting EMT, iron accumulation, and metastasis through ZEB2 and TFRC regulation, suggesting potential therapeutic targets in CRC.

Citing Articles

Hypoxia inducible factor 3-alpha promotes a malignant phenotype in colorectal cancer cells.

Lopez-Mejia A, Moreno-Londono A, Fonseca Camarillo G, Yamamoto-Furusho J, Villanueva-Herrero J, de Leon-Rendon J IUBMB Life. 2025; 77(2):e70007.

PMID: 39981666 PMC: 11843525. DOI: 10.1002/iub.70007.


The emerging role of hypoxia and environmental factors in inflammatory bowel disease.

Villareal L, Xue X Toxicol Sci. 2024; 198(2):169-184.

PMID: 38200624 PMC: 10964750. DOI: 10.1093/toxsci/kfae004.

References
1.
Higgins D, Kimura K, Bernhardt W, Shrimanker N, Akai Y, Hohenstein B . Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest. 2007; 117(12):3810-20. PMC: 2082142. DOI: 10.1172/JCI30487. View

2.
Morales M, Xue X . Targeting iron metabolism in cancer therapy. Theranostics. 2021; 11(17):8412-8429. PMC: 8344014. DOI: 10.7150/thno.59092. View

3.
Xue X, Ramakrishnan S, Anderson E, Taylor M, Zimmermann E, Spence J . Endothelial PAS domain protein 1 activates the inflammatory response in the intestinal epithelium to promote colitis in mice. Gastroenterology. 2013; 145(4):831-41. PMC: 3799890. DOI: 10.1053/j.gastro.2013.07.010. View

4.
Miess H, Dankworth B, Gouw A, Rosenfeldt M, Schmitz W, Jiang M . The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma. Oncogene. 2018; 37(40):5435-5450. PMC: 6173300. DOI: 10.1038/s41388-018-0315-z. View

5.
Ravenna L, Salvatori L, Russo M . HIF3α: the little we know. FEBS J. 2015; 283(6):993-1003. DOI: 10.1111/febs.13572. View